Effect of Serenoa repens extract (Permixon®) on estradiol/testosterone-induced experimental prostate enlargement in the rat

Pharmacological Research

Volumn 34, Issue 3-4, 1996, Pages 171-179

  Paubert Braquet, Monique ^c   Richardson, Fannie O ^a   Servent Saez, Nathalie ^c   Gordon, William C ^a   Monge, Marie Claude ^c   Bazan, Nicolas G ^a   Authie, Dominique ^b   Braquet, Pierre ^c  

^a LSU EYE CENTER   (United States)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^c BIO Inova EuroLab Research Labs   (France)

Author keywords

Benign prostatic hypertrophy (BPH); Cotreatment (E+T); Dorsal prostate (DP); Lipidosterolic extract of serenoa repens (LSESR)

Indexed keywords

ESTRADIOL; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASTRATION; CONTROLLED STUDY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RAT; SABAL;

SERENOA REPENS;

EID: 0030240319     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0085     Document Type: Article

References (25)

1. 1. Murakoshi M, Tagawa M, Inada R, Suzuki M. Effects of testosterone, and testosterone plus estrogen, in the castrated rat ventral prostate: Histopathological and immunocytochemical studies. Tokai J Exp Clin Med 1992; 17: 133.
2. 2. Timm BG, Chandler JA. Ultrastructural and analytical studies on the prostate of castrated rats. The Prostate 1983; 4: 37.
3. 3. Aumüller G, Enderle-Schmitt U, Seitz J, Müntzing J, Chandler JA. Ultrastructure and immunohistochemistry of the lateral prostate in aged rats. The Prostate 1987; 10: 245.
4. 4. Naswlund MJ, Coffey DS. The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth. J Urol 1986; 136: 1136.
5. 5. Tangbanluekal L, Robinette CL. Prolactin mediates estradiol-induced inflammation in the lateral prostate of Wistar Rats. Endocrinology 1993; 132: 2407.
6. 6. Cunah GR, Donjacour AA, Cooke PS, Mee S, Gigsby RM, Higgins SJ, Sugimura Y. The endocrinology and developmental biology of the prostate. Endocrine Rev 1987; 8: 338.
7. 7. Stenger A, Tarayre JP, Carilla E. Etude pharmacologique et biochimique de l'extrait hexanique de Serenoa repens B. Gaz Méd Fr 1982; 89: 2041.
8. R, a new treatment for benign pro static hyperplasia, acts directly at the cytosolic androgen receptor in the rat prostate. Br J Pharamcol 1983; 79: 327.
9. R on testosterone 5 reductase activity of the rat prostate. Br J Pharmacol 1984; 83: 401.
10. 10. Sultan C, Terraza A, Divillier C. Inhibition of androgen metabolism and binding by a liposterolic extract of Serenoa repens B in human foreskin fibroblasts. J Steroid Biochem 1984; 20: 515.
11. 11. Sultan C, Terraza A, Carilla E, Briley M, Descomps B. Anti-androgenic effects of Permixon: In vitro studies. In: Di Silverio F, Steg A, eds. New Trends in BPH Etiopathogenesis. Acta Medica: Roma, 1988 297.
12. 12. Di Silverio F, Tenaglia R. Anti-estrogens and anti-androgens in human benign prostatic hyperplasia. In: Di Silverio F, Neumann F, Tannenbaum M, eds. Ipetrofia Prostatica Benigna. Amsterdam: Excerpta Medica. 1986: p. 117.
13. 13. Di Silverio F, D'Eramo G, Lubrano C, Flammia GP, Sciarra A, Palma E, Caponera M, Sciarra F. Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. Eur Urol 1992; 2: 309.
14. 14. Robinette CL. Sex hormone induced inflammation and fibromuscular growth in the rat lateral prostate. Fed Proc 1987; 46: 525.
15. 15. Robinette CL. Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate. The Prostate 1988; 12: 271.
16. 16. Kinci FA, Benagiano G, Angee I. Sustained release hormonal preparations, 1. Diffusion of various steroids through polymer membranes. Steroids 1968; 11: 673.
17. 17. Stratton LG, Ewing LL, Desjardin C. Efficacy of testosterone-filled polydimethylsiloxane implants in maintaining plasma testosterone in rabbits. J Reprod Fert 1973; 35: 235.
18. 18. Robaire B, Ewing LL, Irby DC, Desjardins C. Interactions of testosterone and 17-β estradiol on the reproductive tract of the male rat. Biol Reprod 1979; 21: 455.
19. 19. Milliken GA, Johnson DE. Using the effects model to analyse balanced two-way treatment structures with unequal subclass numbers. In Analysis of Messy Data. Volume I: Designed Experiments. New York: Van Reinhold, 1984: p. 137.
20. 20. Freund RJ, Littelle RC. SAS for Linear Models, a guide to the ANOVA and GLM procedures. Cary, NC: SAS Institute, Inc, 1981.
21. 21. Moore RA. Benign hypertrophy of the prostate: a morphological study. J Urol 1943; 50: 680.
22. 22. Pradhan BK, Chandra K. Morphology of nodular hyperplasia prostate. J Urol 1975; 113: 210.
23. 23. Lawson RK. Benign prostatic hyperplasia and growth factors. Sq Urol Ausg A 1990; 29: 7.
24. 24. Robinette CL, Trempus CS, Onks DL. A prolactin-like transcript is expressed by some of the lymphocytes found in a prolactin-induced inflammatory process in the rat lateral prostate. Meeting of the federation of American societies for experimental biology, New Orleans, Louisiana, USA, FASEB (3-4). 1993. A20.
25. 25. Theyer G, Kramer G, Assmann I, Sherwood E, Preinfalk W, Marberger M, Zechner O, Steiner GE. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia. Lab Invest 1992; 66: 96.